These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Uric acid nephrolithiasis: An update. Cicerello E Urologia; 2018 Aug; 85(3):93-98. PubMed ID: 29687761 [TBL] [Abstract][Full Text] [Related]
24. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest. Zerwekh JE; Odvina CV; Wuermser LA; Pak CY J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313 [TBL] [Abstract][Full Text] [Related]
25. [Metabolic syndrome and nephrolithiasis]. Kohjimoto Y; Iba A; Sasaki Y; Hara I Hinyokika Kiyo; 2011 Jan; 57(1):43-7. PubMed ID: 21304261 [TBL] [Abstract][Full Text] [Related]
27. Net Acid Excretion and Urinary Organic Anions in Idiopathic Uric Acid Nephrolithiasis. Bobulescu IA; Park SK; Xu LHR; Blanco F; Poindexter J; Adams-Huet B; Davidson TL; Sakhaee K; Maalouf NM; Moe OW Clin J Am Soc Nephrol; 2019 Mar; 14(3):411-420. PubMed ID: 30745301 [TBL] [Abstract][Full Text] [Related]
28. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis. Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013 [TBL] [Abstract][Full Text] [Related]
29. Clinical and metabolic evaluation of patients with history of renal calculi in Qazvin, Iran. Charkhchian M; Samani S; Merat E Ir J Med Sci; 2015 Dec; 184(4):731-5. PubMed ID: 24923966 [TBL] [Abstract][Full Text] [Related]
30. Body size and 24-hour urine composition. Taylor EN; Curhan GC Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145 [TBL] [Abstract][Full Text] [Related]
31. 24-h uric acid excretion and the risk of kidney stones. Curhan GC; Taylor EN Kidney Int; 2008 Feb; 73(4):489-96. PubMed ID: 18059457 [TBL] [Abstract][Full Text] [Related]
32. [Use of citrate in patients with nephrolithiasis]. Marangella M G Ital Nefrol; 2017 Aug; 34(4):51-60. PubMed ID: 28762682 [TBL] [Abstract][Full Text] [Related]
33. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy. Pak CY; Sakhaee K; Fuller CJ Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957 [TBL] [Abstract][Full Text] [Related]
34. Medical and dietary therapy for kidney stone prevention. Gul Z; Monga M Korean J Urol; 2014 Dec; 55(12):775-9. PubMed ID: 25512810 [TBL] [Abstract][Full Text] [Related]
36. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288 [TBL] [Abstract][Full Text] [Related]
37. The spectrum of metabolic abnormalities in patients with cystine nephrolithiasis. Sakhaee K; Poindexter JR; Pak CY J Urol; 1989 Apr; 141(4):819-21. PubMed ID: 2926871 [TBL] [Abstract][Full Text] [Related]
38. [The effect of oral calcium loading on the serum concentrations and urinary excretion of uric acid in patients with recurrent calcium nephrolithiasis and hypercalciuria]. Ivanov I; Tsachev K Vutr Boles; 1990; 29(3):64-8. PubMed ID: 2284802 [TBL] [Abstract][Full Text] [Related]
39. [Diet in the treatment of renal lithiasis. Pathophysiological basis]. Negri AL; Spivacow FR; Del Valle EE Medicina (B Aires); 2013; 73(3):267-71. PubMed ID: 23732207 [TBL] [Abstract][Full Text] [Related]